Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Active not recruiting 2 Withdrawn 1 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 20 Neoplasm Metastasis 4 Neoplasms 3 Melanoma 3 Thyroid Neoplasms 1 Thymus Neoplasms 1 Thrombosis 1 Thromboembolism 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Inflammation 1 Immune System Diseases 1 Hormone Receptor Positive Advanced Breast Cancer 1 Head and Neck Neoplasms 1 HER2+ Breast Cancer 1 Gastrointestinal Neoplasms 1 Estrogen Receptor-positive Breast Cancer 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 ER Positive, HER2 Negative Breast Cancer 1 Colonic Neoplasms 1 Chordoma 1 Cardiovascular Diseases 1

Interventions

Doxorubicin 19 Radiotherapy 10 Ifosfamide 10 apatinib 9 anlotinib 8 Cyclophosphamide 8 camrelizumab 7 Vincristine 5 Dactinomycin 5 toripalimab 3 Trabectedin 3 Radiation Dose Hypofractionation 3 Etoposide 3 Docetaxel 3 ribociclib 2 brostallicin 2 Topotecan 2 Thalidomide 2 Temozolomide 2 Sorafenib 2 Oncolytic Virotherapy 2 Nivolumab 2 Neoadjuvant Therapy 2 Melphalan 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Ipilimumab 2 Immune Checkpoint Inhibitors 2 Gene Expression Profiling 2 Gemcitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Sarcoma × palbociclib × Clear all

NCT03242382 2024-01-23

PalboSarc

Grupo Espanol de Investigacion en Sarcomas

Phase 2 Unknown

Chordoma, Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡